<SEC-DOCUMENT>0001558370-24-001308-index.html : 20240216
<SEC-HEADER>0001558370-24-001308.hdr.sgml : 20240216
<ACCEPTANCE-DATETIME>20240216170429
ACCESSION NUMBER:		0001558370-24-001308
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20240216
DATE AS OF CHANGE:		20240216
EFFECTIVENESS DATE:		20240216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CAPRICOR THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001133869
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-277154
		FILM NUMBER:		24649355

	BUSINESS ADDRESS:	
		STREET 1:		8840 WILSHIRE BLVD
		STREET 2:		2ND FLOOR
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90211
		BUSINESS PHONE:		(310) 358-3200

	MAIL ADDRESS:	
		STREET 1:		8840 WILSHIRE BLVD
		STREET 2:		2ND FLOOR
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nile Therapeutics, Inc.
		DATE OF NAME CHANGE:	20070920

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SMI PRODUCTS INC
		DATE OF NAME CHANGE:	20010206
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>tmb-20240216xs8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: tmb-20240216xs8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tmb-20240216xex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: tmb-20240216xex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>tmb-20240216xex23d1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: tmb-20240216xex23d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>tmb-20240216xexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: tmb-20240216xexfilingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tmb-20240216xex5d1002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tmb-20240216xex5d1002.jpg
</DOCUMENT> </SEC-DOCUMENT>